Download by
Scanning QR Code
No Data
US Stock MarketDetailed Quotes
SMMNY SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS
Watchlist
25.325
-0.200-0.78% Close 09/29 16:00 ET
25.520High25.230Low56.98KVolume
25.506Open25.525Pre Close1.44MTurnover0.00%Turnover Ratio32.68P/E (TTM)56.70BMarket Cap31.92052wk High28.55P/E (Static)2.24BShares19.68852wk Low3.14P/B56.70BFloat Cap37.048Historical High0.52Dividend TTM2.24BShs Float19.079Historical Low2.06%Div YieldTTM1.14%Amplitude25.319Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS Company
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on December 1, 2017 and is headquartered in Erlangen, Germany.
News
These Companies Set to Benefit From Sales of Biogen Alzheimer's Med Leqembi
Global Cardiac Marker Analyzer Market Research Report 2022-2023 & 2028: Critical Role of Cardiac Biomarkers in the Fight Against Heart Disease but Regulatory Challenges Could Hinder Growth
DUBLIN, Sept. 19, 2023 /PRNewswire/ -- The "Global Cardiac Marker Analyzer Market and Forecast, Impact of COVID-19, Product Analysis, Companies Business & Marketing Strategy, Major Deals" report has been added to ResearchAndMarkets.com's offering.
Siemens Healthcare expands production site in Rudolstadt, Germany to produce core components for Walian radiotherapy equipment
A radiotherapy equipment parts manufacturing plant will be built, and the new plant is expected to be officially put into operation in mid-2024, with an investment of about 25 million euros, demonstrating its firm commitment to the Rudolstadt plant Erlangen September 7, 2023 /PRNewswire/ -- Recently, Siemens Healthcare announced the expansion of its production site in Rudolstadt (Rudolstadt), Germany. By mid-2024, a new production building will be built at the site. The new production building will produce the electron accelerators required for radiation sources for Siemens Medical's Varian cancer radiotherapy equipment. The building will also be expanded with a liquid metal sliding shaft